United States · FDA National Drug Code directory
Enhertu
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65597-406_a4106ba4-f398-4663-980c-2b7195283edd
- Product NDC
- 65597-406
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- fam-trastuzumab deruxtecan-nxki
- Labeler
- Daiichi Sankyo Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20191220
- Source listing expiry
- 20271231
Source-listed ingredients
- TRASTUZUMAB DERUXTECAN — 100 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (65597-406-01) / 5 mL in 1 VIAL, SINGLE-DOSE · 65597-406-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →